Search

Heterogenous Lung Organoids

About

Advanced Lung Organoids for Disease Research

Current lung organoid models face challenges in scalability and accuracy due to high costs, invasive procedures, and limited representation of lung regions. This project introduces a new approach using tracheal/bronchial and mesenchymal cells in hydrogels to create lung organoids that mature in just 21 days. These organoids replicate diverse lung structures and are effective for studying adult lung diseases and viral infections such as SARS-CoV-2 and influenza. This cost-effective, scalable model enhances drug testing and respiratory disease research

Student

  • Alicia Reyes Valenzuela

    Alicia Reyes Valenzuela

    Dr. Alicia Reyes Valenzuela is the founder and CEO of PulmonaVat, specializing in lung organoid generation and tissue engineering. With master's and doctoral degrees in Biological and Biomedical Engineering from McGill University and inspired by her experience during the COVID-19 pandemic, she developed heterogeneous lung organoids that mimic the complexity of human lungs. Her work focuses on revolutionizing drug efficacy testing across diverse populations to prepare for future health crises. A recipient of honors like CONAHCYT and the Young Scientist Award from PETA, Alicia advocates for in-vitro models that reduce reliance on animal testing in personalized medicine and drug discovery.more

Discover
the
Project


Similiar Projects

AiSee

AiSee

Wearable technology

National University of Singapore

AI-powered wearable device for real-time visual assistance

AmCURE Antibiotic

AmCURE Antibiotic

Infection risk reduction

Targeted antimicrobial treatment for resistant infections

ANGIE

ANGIE

Patient comfort

ETH Zurich

Magnetically guided microcapsules for brain tumour treatment

Belly Buddy

Belly Buddy

Health and Well-being

Harvard University

Early detection and non-invasive correction of breech pregnancies